HBV Pre-S1-Derived Myristoylated Peptide (Myr47): Identification of the Inhibitory Activity on the Cellular Uptake of Lipid Nanoparticles

The Myr47 lipopeptide, consisting of hepatitis B virus (HBV) pre-S1 domain (myristoylated 2–48 peptide), is an effective commercialized anti-HBV drug that prevents the interaction of HBV with sodium taurocholate cotransporting polypeptide (NTCP) on human hepatocytes, an activity which requires both...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Masaya Nanahara, Ya-Ting Chang, Masaharu Somiya, Shun’ichi Kuroda
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2021-05-01
Edice:	Viruses
Témata:	hepatitis B virus (HBV) Myr47 lipopeptide cellular uptake liposomes sodium taurocholate cotransporting polypeptide (NTCP) HBV surface antigen (HBsAg)
On-line přístup:	https://www.mdpi.com/1999-4915/13/5/929
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!